Mani, Inc. (TYO:7730)

Market Cap	143.72B +11.8%
Revenue (ttm)	32.08B +9.9%
Net Income	6.56B +20.1%
EPS	66.55 +20.1%
Shares Out	98.50M
PE Ratio	21.92
Forward PE	20.32
Dividend	41.00 (2.79%)
Ex-Dividend Date	Aug 28, 2026

Volume	83,400
Open	1,465.00
Previous Close	1,459.00
Day's Range	1,461.00 - 1,473.00
52-Week Range	1,238.00 - 1,955.00
Beta	0.38
Analysts	Buy
Price Target	1,845.71 (+25.47%)
Earnings Date	Oct 15, 2026

About Mani, Inc.

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needle...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1956
• Employees: 4,140
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7730

Financial Performance

In fiscal year 2025, Mani, Inc.'s revenue was 29.97 billion, an increase of 5.10% compared to the previous year's 28.51 billion. Earnings were 4.64 billion, a decrease of -26.14%.

Analyst Summary

According to 7 analysts, the average rating for 7730 stock is "Buy." The 12-month stock price target is ¥1,846, which is an increase of 25.47% from the latest price.

Price Target

¥1,846

(25.47% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error